PriceTargets.com logo

Aphria - APHA Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$16.55 As of 05/5/2021 12:59 AM ET
▼ -0.98 (-5.59%)

This chart shows the closing price for APHA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aphria Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APHA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APHA

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Aphria in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$16.55.

This chart shows the closing price for APHA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Aphria. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/13/2021Haywood SecuritiesLower TargetHoldC$26.00 ➝ C$20.00
4/13/2021Pi FinancialDowngradeBuy ➝ NeutralC$11.00 ➝ C$16.00
4/13/2021Standpoint ResearchLower TargetNeutralC$22.00 ➝ C$18.00
4/12/2021CIBCBoost TargetOutperformC$28.00
4/6/2021Stifel NicolausBoost TargetC$15.50 ➝ C$22.00
1/19/2021Stifel NicolausBoost TargetC$9.80 ➝ C$15.50
1/15/2021Alliance Global PartnersSet TargetC$20.00
1/15/2021Haywood SecuritiesDowngradeBuy ➝ HoldC$12.25 ➝ C$14.00
1/15/2021CIBCBoost TargetC$12.50 ➝ C$18.00
12/18/2020CormarkBoost TargetC$8.00 ➝ C$10.75
12/17/2020Pi FinancialSet TargetBuyC$11.00
12/17/2020Stifel NicolausDowngradeBuy ➝ HoldC$8.25 ➝ C$9.80
12/17/2020Alliance Global PartnersBoost TargetC$9.00 ➝ C$12.00
12/4/2020Jefferies Financial GroupBoost TargetC$9.42 ➝ C$12.80
12/2/2020Haywood SecuritiesBoost TargetC$8.25 ➝ C$12.25
11/13/2020CormarkBoost TargetC$7.00 ➝ C$8.00
11/9/2020Pi FinancialBoost TargetBuyC$10.00 ➝ C$11.00
10/22/2020Jefferies Financial GroupLower TargetC$10.00 ➝ C$9.42
10/16/2020CormarkBoost TargetC$6.00 ➝ C$7.00
10/16/2020CIBCBoost TargetC$7.50 ➝ C$8.00
10/16/2020Pi FinancialSet TargetBuyC$10.00
10/9/2020Stifel NicolausBoost TargetC$8.00 ➝ C$8.25
8/5/2020Jefferies Financial GroupLower TargetC$9.00 ➝ C$7.00
7/30/2020Pi FinancialBoost TargetBuyC$8.00 ➝ C$10.00
7/30/2020CIBCBoost TargetC$6.00 ➝ C$7.50
4/16/2020CIBCLower TargetC$7.00 ➝ C$6.00
4/16/2020Eight CapitalUpgradeNeutral ➝ BuyC$9.00 ➝ C$8.00
4/16/2020Jefferies Financial GroupLower TargetC$10.00 ➝ C$9.00
4/16/2020Stifel NicolausBoost TargetC$4.50 ➝ C$5.30
4/14/2020Pi FinancialSet TargetBuyC$8.00
3/19/2020Bank of AmericaUpgradeNeutral ➝ Buy
2/19/2020Bryan, Garnier & CoLower TargetC$12.40 ➝ C$6.50
1/21/2020Alliance Global PartnersReiterated RatingBuyC$11.00
1/20/2020Jefferies Financial GroupLower TargetC$11.00 ➝ C$10.30
1/15/2020Pi FinancialLower TargetBuyC$9.00 ➝ C$8.00
1/15/2020CIBCUpgradeUnderperform ➝ NeutralC$6.50 ➝ C$7.00
10/16/2019CormarkLower TargetC$14.00 ➝ C$8.00
10/16/2019Eight CapitalLower TargetC$11.00 ➝ C$9.00
10/16/2019CIBCLower TargetC$7.00 ➝ C$6.50
10/11/2019Jefferies Financial GroupLower TargetC$15.00 ➝ C$11.00
8/2/2019CIBCBoost TargetC$6.50 ➝ C$7.00
7/26/2019CIBCLower TargetC$12.00 ➝ C$6.50
5/24/2019Jefferies Financial GroupReiterated RatingBuyC$15.00
(Data available from 4/23/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Aphria logo
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Read More

Today's Range

Now: C$16.55
Low: C$16.41
High: C$17.52

50 Day Range

MA: C$16.55
Low: C$16.55
High: C$16.55

52 Week Range

Now: C$16.55
Low: C$3.93
High: C$40.93

Volume

9,609,357 shs

Average Volume

6,161,365 shs

Market Capitalization

C$5.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aphria?

The following Wall Street sell-side analysts have issued reports on Aphria in the last twelve months:
View the latest analyst ratings for APHA.

What is the current price target for Aphria?

0 Wall Street analysts have set twelve-month price targets for Aphria in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Aphria in the next year.
View the latest price targets for APHA.

What is the current consensus analyst rating for Aphria?

Aphria currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for APHA.

What other companies compete with Aphria?

Other companies that are similar to Aphria include Bausch Health Companies, Tilray Brands, Valeant Pharmaceuticals International, BELLUS Health and Trillium Therapeutics. Learn More about companies similar to Aphria.

How do I contact Aphria's investor relations team?

Aphria's physical mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company's listed phone number is 844-427-4742. The official website for Aphria is www.aphria.com. Learn More about contacing Aphria investor relations.